CDEK
← All organizations

BioCryst

For profitContributed to NMEWebsite ↗

Also known as: BIOCRYST | BioCryst Pharmaceuticals | BIOCRYST PHARMACEUTICALS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Nov 2, 1999

First marketed drug

Dec 19, 2014

First NDA

Dec 19, 2014

Last known activity

Dec 11, 2025

Timeline

1980s

  1. Jan 1, 1986

    BioCryst— Founded

2010s

  1. Oct 18, 2012

    Presidio Pharmaceuticals— Acquired

  2. Dec 19, 2014

    peramivir— NDA Organization

2020s

  1. Dec 3, 2020

    berotralstat— Marketing Organization

  2. Dec 3, 2020

    berotralstat— NDA Secondary Org

  3. Oct 15, 2025

    Astria Therapeutics, Inc.— Acquired

Drugs by trial phase (28 distinct, 67 trials)

Phase 3 (4 own, 1 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (2)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Durham, NC, US Jan 1, 1986
First NDA
Dec 19, 2014
Last known activity
Dec 11, 2025

Designations held

  • Orphan drug
  • Fast track